Publications found:
264
Sort by:
Takotsubo Syndrome Therapeutic Market Forecasts to 2034 – Global Analysis By Product Type (Anticoagulants, Beta-Blockers, Aldosterone Receptor Blockers, Statins, Diuretics, Angiotensin-Converting Enzyme (ACE) Inhibitors, Dual Antiplatelet Therapy (DAPT) and Other Product Types), Diagnosis, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Takotsubo Syndrome Therapeutic Market is accounted for $0.52 billion in 2026 and is expected to reach $0.99 billion by 2034 growing at a CAGR of 8.3% during th...
May 2026
200 pages
Global Anti-ANGPTL3 Antibody Drugs Market Growth 2026-2032
US$ 3,660.00
The global Anti-ANGPTL3 Antibody Drugs market size is predicted to grow from US$ 145 million in 2025 to US$ 295 million in 2032; it is expected to grow at a CAGR of 10.0% from 2026 to 2032. In 2025, g...
May 2026
84 pages
Losartan Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Contract Manufacturing Organizations, In-House), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Losartan market is anticipated to expand from USD 743.21 million in 2025 to USD 933.37 million by 2031, reflecting a compound annual growth rate (CAGR) of 3.87%. As an angiotensin II recept...
May 2026
185 pages
Global Cardiac Myosin Inhibitors Market Growth 2026-2032
US$ 3,660.00
The global Cardiac Myosin Inhibitors market size is predicted to grow from US$ 815 million in 2025 to US$ 1770 million in 2032; it is expected to grow at a CAGR of 12.0% from 2026 to 2032. In 2025, gl...
April 2026
85 pages
Global Myosin Inhibitors Market Growth 2026-2032
US$ 3,660.00
The global Myosin Inhibitors market size is predicted to grow from US$ 908 million in 2025 to US$ 2058 million in 2032; it is expected to grow at a CAGR of 12.8% from 2026 to 2032. In 2025, global Myo...
April 2026
85 pages
Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2026-2034
US$ 3,999.00
The global congestive heart failure drugs market size reached USD 10.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.6 Billion by 2034, exhibiting a growth rate (CAG...
April 2026
150 pages
Hypercholesterolemia Market Size by Type (Type 1, Type 2A, Type 2B, Type 3, Type 4, Type 5, and Others), Diagnosis and Treatment (Diagnosis, Treatment), Patient (Pediatric, Adults, Geriatric), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), and Region ?2026-2034?
US$ 3,999.00
The global hypercholesterolemia market size reached USD 22.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 65.0 Billion by 2034, exhibiting a growth rate (CAGR) of 12.0...
April 2026
136 pages
Atrial Fibrillation Treatment Market Report by Disorder Type (Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Permanent Atrial Fibrillation, and Others), Treatment Type (Medical Procedures, Medication), End-User (Hospitals, Cardiac Labs, Ambulatory Surgical Centers, and Others), and Region 2026-2034
US$ 3,999.00
The global atrial fibrillation treatment market size reached USD 9.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 21.2 Billion by 2034, exhibiting a growth rate (CAGR)...
April 2026
139 pages
Stroke Management Market Report by Type (Diagnostics, Therapeutics), Application (Ischemic Stroke, Haemorrhagic Stroke, and Others), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others), and Region 2026-2034
US$ 3,999.00
The global stroke management market size reached USD 40.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 65.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.60% d...
April 2026
140 pages
Hypertrophic Cardiomyopathy Therapeutics Market Size, Share & Trends Analysis Report By Drug Class, (Beta Blockers, Calcium Channel Blockers), By Disease Type, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global hypertrophic cardiomyopathy therapeutics market size was estimated at USD 1.43 billion in 2025 and is projected to reach USD 2.16 billion by 2033, growing at a CAGR of 5.5% from 2026 to 203...
March 2026
150 pages
Global Warfarin Sodium Tablets Market Growth 2026-2032
US$ 3,660.00
The global Warfarin Sodium Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Warfarin is an oral anticoa...
March 2026
82 pages
Global Doxazosin Mesylate Tablets Market Growth 2026-2032
US$ 3,660.00
The global Doxazosin Mesylate Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Doxazosin is commonly us...
March 2026
105 pages
Global Valsartan Capsules Market Growth 2026-2032
US$ 3,660.00
The global Valsartan Capsules market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Valsartan capsules are a type of...
March 2026
93 pages
Global Vascular Health Supplements Market Growth 2026-2032
US$ 3,660.00
The global Vascular Health Supplements market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Vascular Health supplem...
March 2026
125 pages
Global Acipimox API Market Growth 2026-2032
US$ 3,660.00
The global Acipimox API market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Acipimox API refers to the pure, activ...
March 2026
88 pages
Global Bempedoic Acid Products Market Growth 2026-2032
US$ 3,660.00
The global Bempedoic Acid Products market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Bempedoic acid products ref...
March 2026
78 pages
Global Bile Acid Resins Market Growth 2026-2032
US$ 3,660.00
The global Bile Acid Resins market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Bile acid resins, also known as bi...
March 2026
138 pages
Global Cholesterol Lowering Drugs Market Growth 2026-2032
US$ 3,660.00
The global Cholesterol Lowering Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Cholesterol-lowering dru...
March 2026
139 pages
